240 related articles for article (PubMed ID: 7658589)
1. Quantification of crystal growth of calcium oxalate in gel and its modification by urinary constituents in a new flow model of crystallization.
Achilles W; Freitag R; Kiss B; Riedmiller H
J Urol; 1995 Oct; 154(4):1552-6. PubMed ID: 7658589
[TBL] [Abstract][Full Text] [Related]
2. Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals.
Ryall RL; Chauvet MC; Grover PK
BJU Int; 2005 Sep; 96(4):654-63. PubMed ID: 16104927
[TBL] [Abstract][Full Text] [Related]
3. Factors affecting calcium oxalate dihydrate fragmented calculi regrowth.
Costa-Bauzá A; Perelló J; Isern B; Sanchis P; Grases F
BMC Urol; 2006 Jul; 6():16. PubMed ID: 16822299
[TBL] [Abstract][Full Text] [Related]
4. In vitro formation of "urinary stones": generation of spherulites of calcium phosphate in gel and overgrowth with calcium oxalate using a new flow model of crystallization.
Achilles W; Jöckel U; Schaper A; Burk M; Riedmiller H
Scanning Microsc; 1995 Jun; 9(2):577-85; discussion 585-6. PubMed ID: 8714750
[TBL] [Abstract][Full Text] [Related]
5. Intracrystalline proteins and urolithiasis: a synchrotron X-ray diffraction study of calcium oxalate monohydrate.
Fleming DE; Van Riessen A; Chauvet MC; Grover PK; Hunter B; van Bronswijk W; Ryall RL
J Bone Miner Res; 2003 Jul; 18(7):1282-91. PubMed ID: 12854839
[TBL] [Abstract][Full Text] [Related]
6. Urinary glycosaminoglycans are selectively included into calcium oxalate crystals precipitated from whole human urine.
Suzuki K; Mayne K; Doyle IR; Ryall RL
Scanning Microsc; 1994; 8(3):523-30. PubMed ID: 7747154
[TBL] [Abstract][Full Text] [Related]
7. Fibronectin as a potent inhibitor of calcium oxalate urolithiasis.
Tsujihata M; Miyake O; Yoshimura K; Kakimoto KI; Takahara S; Okuyama A
J Urol; 2000 Nov; 164(5):1718-23. PubMed ID: 11025758
[TBL] [Abstract][Full Text] [Related]
8. Calcium oxalate dihydrate crystal growth.
Werness PG; Duckworth SC; Smith LH
Invest Urol; 1979 Nov; 17(3):230-3. PubMed ID: 40922
[TBL] [Abstract][Full Text] [Related]
9. Calcium oxalate crystal growth in the presence of mucin.
Akbarieh M; Tawashi R
Scanning Microsc; 1991 Dec; 5(4):1019-26; discussion 1026-7. PubMed ID: 1822027
[TBL] [Abstract][Full Text] [Related]
10. Role of urinary bikunin in the inhibition of calcium oxalate crystallization.
Atmani F; Khan SR
J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S385-8. PubMed ID: 10541269
[TBL] [Abstract][Full Text] [Related]
11. Magnesium, citrate, magnesium citrate and magnesium-alkali citrate as modulators of calcium oxalate crystallization in urine: observations in patients with recurrent idiopathic calcium urolithiasis.
Schwille PO; Schmiedl A; Herrmann U; Fan J; Gottlieb D; Manoharan M; Wipplinger J
Urol Res; 1999 Apr; 27(2):117-26. PubMed ID: 10424393
[TBL] [Abstract][Full Text] [Related]
12. Effects of citrate on the different phases of calcium oxalate crystallization.
Tiselius HG; Berg C; Fornander AM; Nilsson MA
Scanning Microsc; 1993 Mar; 7(1):381-9; discussion 389-90. PubMed ID: 8316807
[TBL] [Abstract][Full Text] [Related]
13. Factors determining types and morphologies of calcium oxalate crystals: molar concentrations, buffering, pH, stirring and temperature.
Thongboonkerd V; Semangoen T; Chutipongtanate S
Clin Chim Acta; 2006 May; 367(1-2):120-31. PubMed ID: 16458875
[TBL] [Abstract][Full Text] [Related]
14. [Chemical structure of dicarboxylic acids and their capacity inhibiting of calcium oxalate crystal growth].
Deng SP; Hu P; Ouyang JM
Guang Pu Xue Yu Guang Pu Fen Xi; 2007 Oct; 27(10):1981-4. PubMed ID: 18306777
[TBL] [Abstract][Full Text] [Related]
15. Architecture of mixed calcium oxalate dihydrate and monohydrate stones.
Iwata H; Iio S; Nishio S; Takeuchi M
Scanning Microsc; 1992 Mar; 6(1):231-7; discussion 237-8. PubMed ID: 1626242
[TBL] [Abstract][Full Text] [Related]
16. Factors affecting the regrowth of renal stones in vitro: a contribution to the understanding of renal stone development.
Costa-Bauzá A; Isern B; Perelló J; Sanchis P; Grases F
Scand J Urol Nephrol; 2005; 39(3):194-9. PubMed ID: 16118089
[TBL] [Abstract][Full Text] [Related]
17. Effects of inositol hexaphosphate (phytate) on calcium binding, calcium oxalate crystallization and in vitro stone growth.
Saw NK; Chow K; Rao PN; Kavanagh JP
J Urol; 2007 Jun; 177(6):2366-70. PubMed ID: 17509360
[TBL] [Abstract][Full Text] [Related]
18. Aspects of calcium oxalate crystallization: theory, in vitro studies, and in vivo implementation.
Rodgers A
J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S351-4. PubMed ID: 10541262
[TBL] [Abstract][Full Text] [Related]
19. Minipump induced hyperoxaluria and crystal deposition in rats: a model for calcium oxalate urolithiasis.
Marengo SR; Chen D; MacLennan GT; Resnick MI; Jacobs GH
J Urol; 2004 Mar; 171(3):1304-8. PubMed ID: 14767338
[TBL] [Abstract][Full Text] [Related]
20. Whole urinary proteins coat calcium oxalate monohydrate crystals to greatly decrease their adhesion to renal cells.
Kumar V; Farell G; Lieske JC
J Urol; 2003 Jul; 170(1):221-5. PubMed ID: 12796693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
